Liabilities / Assets
56th percentile
Higher debt load relative to assets than 56% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.37x
Liabilities / Revenue
41st percentile
Higher debt load relative to revenue than 41% of similar nonprofits.
Net Margin
23rd percentile
Higher net margin than 23% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
15th percentile
Faster asset growth than 15% of similar nonprofits.
Revenue Growth
27th percentile
Faster revenue growth than 27% of similar nonprofits.
Balance Sheet
Assets
Down$155,465,890
Down $4,337,390 (-2.7%) from 2019
Net Assets
Down$98,621,367
Down $3,526,561 (-3.5%) from 2019
Liabilities
Down$56,844,523
Down $810,829 (-1.4%) from 2019
Revenue And Expenses
Revenue
Down$137,184,154
Down $8,882,354 (-6.1%) from 2019
Expenses
Up$142,008,508
Up $655,349 (+0.5%) from 2019
Net Income
Down-$4,824,354
Down $9,537,703 (-202%) from 2019
Historical Trend
Filing Detail Status
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview
Mission
Inspired by the gift of donation from our communities, allosource responsibly provides innovative cellular and tissue allografts to advance patient healing.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2020 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $155,465,890
- Liabilities
- $56,844,523
- Net assets
- $98,621,367
- Revenue
- $137,184,154
- Expenses
- $142,008,508
- Net income
- -$4,824,354